nodes	percent_of_prediction	percent_of_DWPC	metapath
Biperiden—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0399	0.0503	CbGpPWpGaD
Biperiden—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.0246	0.119	CbGeAlD
Biperiden—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0147	0.0709	CbGeAlD
Biperiden—CHRM1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0144	0.0182	CbGpPWpGaD
Biperiden—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0144	0.0181	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0142	0.0179	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0141	0.0178	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0139	0.0176	CbGpPWpGaD
Biperiden—CHRM1—forebrain—attention deficit hyperactivity disorder	0.0133	0.0645	CbGeAlD
Biperiden—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.0133	0.0645	CbGeAlD
Biperiden—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.0129	0.0621	CbGeAlD
Biperiden—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.0126	0.0607	CbGeAlD
Biperiden—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.0124	0.0599	CbGeAlD
Biperiden—CHRM1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0121	0.0153	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0119	0.0151	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0119	0.0149	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0117	0.0148	CbGpPWpGaD
Biperiden—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.0113	0.0545	CbGeAlD
Biperiden—CHRNA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0108	0.0136	CbGpPWpGaD
Biperiden—CHRNA2—brain—attention deficit hyperactivity disorder	0.0102	0.0493	CbGeAlD
Biperiden—CHRM1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00854	0.0108	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00843	0.0106	CbGpPWpGaD
Biperiden—CHRNA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00827	0.0104	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00822	0.0104	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00811	0.0102	CbGpPWpGaD
Biperiden—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00796	0.0385	CbGeAlD
Biperiden—CHRM1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00794	0.01	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00784	0.00989	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00769	0.0097	CbGpPWpGaD
Biperiden—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00766	0.037	CbGeAlD
Biperiden—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00759	0.00958	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00756	0.00954	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00747	0.00942	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00746	0.00941	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00737	0.0093	CbGpPWpGaD
Biperiden—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00725	0.035	CbGeAlD
Biperiden—CHRM1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00718	0.00906	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00709	0.00894	CbGpPWpGaD
Biperiden—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00698	0.0337	CbGeAlD
Biperiden—CHRM1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00696	0.00877	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00687	0.00866	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00668	0.00842	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00659	0.00831	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00647	0.00815	CbGpPWpGaD
Biperiden—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00646	0.0312	CbGeAlD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00638	0.00805	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00636	0.00802	CbGpPWpGaD
Biperiden—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00632	0.00797	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00628	0.00792	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00627	0.00791	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0062	0.00781	CbGpPWpGaD
Biperiden—CHRM2—brain—attention deficit hyperactivity disorder	0.00608	0.0294	CbGeAlD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00585	0.00737	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00577	0.00728	CbGpPWpGaD
Biperiden—CHRM1—brain—attention deficit hyperactivity disorder	0.00554	0.0268	CbGeAlD
Biperiden—CHRNA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00552	0.00696	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00487	0.00614	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00481	0.00607	CbGpPWpGaD
Biperiden—CHRNA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00475	0.00599	CbGpPWpGaD
Biperiden—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00465	0.0224	CbGeAlD
Biperiden—CHRNA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00441	0.00557	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00441	0.00556	CbGpPWpGaD
Biperiden—CHRNA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00423	0.00534	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0041	0.00517	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00404	0.0051	CbGpPWpGaD
Biperiden—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00395	0.00498	CbGpPWpGaD
Biperiden—CHRNA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00394	0.00496	CbGpPWpGaD
Biperiden—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00393	0.019	CbGeAlD
Biperiden—CHRNA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00364	0.00459	CbGpPWpGaD
Biperiden—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00351	0.0169	CbGeAlD
Biperiden—CHRNA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00338	0.00427	CbGpPWpGaD
Biperiden—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00338	0.0163	CbGeAlD
Biperiden—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00337	0.00425	CbGpPWpGaD
Biperiden—CHRNA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00335	0.00422	CbGpPWpGaD
Biperiden—CHRNA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00332	0.00419	CbGpPWpGaD
Biperiden—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0033	0.0159	CbGeAlD
Biperiden—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00327	0.00413	CbGpPWpGaD
Biperiden—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00307	0.0148	CbGeAlD
Biperiden—CHRNA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00302	0.0038	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00296	0.00373	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00283	0.00357	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00278	0.0035	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00274	0.00346	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00272	0.00343	CbGpPWpGaD
Biperiden—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00272	0.00343	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0027	0.00341	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00269	0.00339	CbGpPWpGaD
Biperiden—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00269	0.00339	CbGpPWpGaD
Biperiden—CYP2D6—brain—attention deficit hyperactivity disorder	0.00268	0.0129	CbGeAlD
Biperiden—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00267	0.00336	CbGpPWpGaD
Biperiden—CHRNA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00256	0.00323	CbGpPWpGaD
Biperiden—CHRNA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00255	0.00321	CbGpPWpGaD
Biperiden—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00252	0.0122	CbGeAlD
Biperiden—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00243	0.00307	CbGpPWpGaD
Biperiden—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00243	0.0117	CbGeAlD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00238	0.003	CbGpPWpGaD
Biperiden—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00237	0.0115	CbGeAlD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.00296	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00234	0.00295	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00233	0.00294	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0023	0.0029	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00226	0.00285	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00226	0.00285	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00214	0.00269	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00201	0.00253	CbGpPWpGaD
Biperiden—ABCB1—brain—attention deficit hyperactivity disorder	0.00193	0.00932	CbGeAlD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00189	0.00238	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00187	0.00236	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00187	0.00236	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00186	0.00235	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00181	0.00229	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00181	0.00229	CbGpPWpGaD
Biperiden—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00179	0.00226	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00179	0.00226	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00178	0.00224	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00176	0.00222	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00175	0.00221	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00175	0.00221	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.0017	0.00215	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00165	0.00208	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00164	0.00207	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00164	0.00207	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00163	0.00205	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00162	0.00204	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0016	0.00201	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00158	0.00199	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00155	0.00196	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00153	0.00193	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00153	0.00193	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00153	0.00193	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00151	0.00191	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00151	0.0019	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00148	0.00187	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00147	0.00185	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00146	0.00184	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00144	0.00182	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.00182	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00143	0.0018	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00142	0.00179	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00141	0.00178	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00139	0.00176	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00139	0.00175	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00139	0.00175	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00137	0.00173	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00134	0.00169	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00133	0.00167	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00131	0.00166	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0013	0.00163	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00127	0.0016	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00126	0.00158	CbGpPWpGaD
Biperiden—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00125	0.00158	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00125	0.00158	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00123	0.00156	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00156	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00123	0.00155	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00122	0.00154	CbGpPWpGaD
Biperiden—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00122	0.00153	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00121	0.00153	CbGpPWpGaD
Biperiden—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0012	0.00151	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00115	0.00145	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00114	0.00143	CbGpPWpGaD
Biperiden—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00109	0.00137	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00108	0.00136	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00106	0.00134	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00129	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00127	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.001	0.00127	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.001	0.00126	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000991	0.00125	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000987	0.00124	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000969	0.00122	CbGpPWpGaD
Biperiden—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000958	0.00121	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000956	0.00121	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000952	0.0012	CbGpPWpGaD
Biperiden—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000951	0.0012	CbGpPWpGaD
Biperiden—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000945	0.00119	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00094	0.00119	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00094	0.00119	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00094	0.00119	CbGpPWpGaD
Biperiden—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000938	0.00118	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00093	0.00117	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000928	0.00117	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000928	0.00117	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000918	0.00116	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000911	0.00115	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0009	0.00113	CbGpPWpGaD
Biperiden—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000895	0.00113	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000876	0.0011	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000865	0.00109	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000819	0.00103	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000809	0.00102	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000806	0.00102	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000795	0.001	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000736	0.000927	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000696	0.000877	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000687	0.000866	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00064	0.000806	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000632	0.000796	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000631	0.000796	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000624	0.000786	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000614	0.000774	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000608	0.000767	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000608	0.000767	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000606	0.000764	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0006	0.000757	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000565	0.000713	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000558	0.000704	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000552	0.000696	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000549	0.000693	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000547	0.00069	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000545	0.000687	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000542	0.000684	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00054	0.000681	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000538	0.000679	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000538	0.000678	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000531	0.00067	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000531	0.00067	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000531	0.00067	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000528	0.000666	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000525	0.000661	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000521	0.000657	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000513	0.000647	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000507	0.000639	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000497	0.000627	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000495	0.000624	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000491	0.000619	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000489	0.000616	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000489	0.000616	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000483	0.000609	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000482	0.000608	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000476	0.000601	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00045	0.000567	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000444	0.00056	CbGpPWpGaD
Biperiden—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000436	0.00055	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000416	0.000524	CbGpPWpGaD
Biperiden—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000401	0.000505	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000392	0.000494	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000373	0.000471	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000368	0.000464	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000347	0.000437	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000342	0.000432	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000326	0.000411	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000322	0.000406	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000315	0.000397	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000311	0.000392	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000303	0.000382	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000299	0.000377	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000294	0.00037	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00029	0.000366	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000289	0.000364	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000287	0.000362	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000287	0.000362	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000285	0.000359	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000285	0.000359	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000282	0.000356	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000281	0.000355	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00027	0.000341	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00027	0.000341	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000266	0.000335	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000266	0.000335	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000262	0.000331	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000262	0.000331	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000247	0.000312	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000229	0.000289	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000218	0.000275	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000216	0.000273	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000206	0.000259	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000186	0.000235	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000184	0.000232	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000174	0.000219	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000173	0.000218	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000164	0.000207	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000163	0.000205	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.85e-05	0.000124	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.73e-05	0.000123	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	7.45e-05	9.4e-05	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.02e-05	8.86e-05	CbGpPWpGaD
